Application of telemedicine in patients with breast cancer-related lymphedema: a scoping review
10.3760/cma.j.cn115682-20240721-04089
- VernacularTitle:远程医疗在乳腺癌相关淋巴水肿患者中应用的范围综述
- Author:
Siyi ZHANG
1
;
Famei TU
;
Yufen XIE
;
Xin ZHANG
;
Qifan FENG
;
Jimin WU
Author Information
1. 南昌大学，江西医学院，护理学院，南昌 330000
- Publication Type:Journal Article
- Keywords:
Review;
Breast cancer-related lymphedema;
Telemedicine;
Mobile health
- From:
Chinese Journal of Modern Nursing
2025;31(5):576-583
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To conduct a scoping review on the application of telemedicine in patients with breast cancer-related lymphedema (BCRL), to generalize and summarize the intervention methods, application forms, outcome indicators and effects of telemedicine, so as to provide a reference for healthcare professionals to implement interventions.Methods:Computerized searches of PubMed, Web of Science, Embase, Cochrane Library, CINAHL, China National Knowledge Infrastructure, Wanfang Data, China Biology Medicine disc, and VIP were performed with a search period from their establishment to June 1, 2024. The included articles were screened, summarized and analyzed.Results:A total of 14 papers were included. Telemedicine intervention methods included tele-education, tele-exercise, tele-monitoring, tele-consultation, tele-psychological interventions, tele-visits, and tele-evaluation. Application forms involved web-based cloud platforms, social network service systems, telemedicine APPs, and remote portable monitoring devices. Outcome indicators included physical indicators, psychological indicators, quality of life, incidence of lymphedema, degree of lymphedema symptoms, and feasibility indicators.Conclusions:Telemedicine relies on web-based platforms and social network service software to conduct tele-education, tele-consultation, and tele-exercise for BCRL patients, and its feasibility and effectiveness have been proven. In the future, it is necessary to accelerate the establishment of breast cancer telemedicine centers, optimize the telemedicine service team, and increase the investment in the development of portable lymphedema telemonitoring equipment, so as to build a comprehensive and perfect breast cancer telemedicine system and improve the effectiveness of the prevention and treatment of BCRL.
